pioglitazone has been researched along with Vasculitis in 5 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
Vasculitis: Inflammation of any one of the blood vessels, including the ARTERIES; VEINS; and rest of the vasculature system in the body.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hasan, DM | 1 |
| Starke, RM | 1 |
| Gu, H | 1 |
| Wilson, K | 1 |
| Chu, Y | 1 |
| Chalouhi, N | 1 |
| Heistad, DD | 1 |
| Faraci, FM | 1 |
| Sigmund, CD | 1 |
| Vinik, A | 1 |
| Parson, H | 1 |
| Ullal, J | 1 |
| Takase, H | 1 |
| Nakazawa, A | 1 |
| Yamashita, S | 1 |
| Toriyama, T | 1 |
| Sato, K | 1 |
| Ueda, R | 1 |
| Dohi, Y | 1 |
| Forst, T | 1 |
| Karagiannis, E | 1 |
| Lübben, G | 1 |
| Hohberg, C | 1 |
| Schöndorf, T | 1 |
| Dikta, G | 1 |
| Drexler, M | 1 |
| Morcos, M | 1 |
| Dänschel, W | 1 |
| Borchert, M | 1 |
| Pfützner, A | 1 |
| Schaller, G | 1 |
| Kolodjaschna, J | 1 |
| Pleiner, J | 1 |
| Mittermayer, F | 1 |
| Kapiotis, S | 1 |
| Schmetterer, L | 1 |
| Wolzt, M | 1 |
1 review available for pioglitazone and Vasculitis
| Article | Year |
|---|---|
The role of PPARs in the microvascular dysfunction in diabetes.
Topics: Animals; Diabetes Mellitus, Type 2; Fatty Acids; Humans; Hypoglycemic Agents; Insulin Resistance; Mi | 2006 |
2 trials available for pioglitazone and Vasculitis
| Article | Year |
|---|---|
Pioglitazone produces rapid and persistent reduction of vascular inflammation in patients with hypertension and type 2 diabetes mellitus who are receiving angiotensin II receptor blockers.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Diabetes Mellitus, | 2007 |
Pleiotrophic and anti-inflammatory effects of pioglitazone precede the metabolic activity in type 2 diabetic patients with coronary artery disease.
Topics: Aged; Anti-Inflammatory Agents; Biomarkers; Blood Glucose; C-Reactive Protein; Coronary Artery Disea | 2008 |
2 other studies available for pioglitazone and Vasculitis
| Article | Year |
|---|---|
Smooth Muscle Peroxisome Proliferator-Activated Receptor γ Plays a Critical Role in Formation and Rupture of Cerebral Aneurysms in Mice In Vivo.
Topics: Aneurysm, Ruptured; Angiotensin II; Anilides; Animals; Cerebral Arteries; Endothelium, Vascular; Gen | 2015 |
Pioglitazone does not affect vascular or inflammatory responses after endotoxemia in humans.
Topics: Adult; Brachial Artery; Endothelium, Vascular; Endotoxemia; Erythrocytes; Humans; Hypoglycemic Agent | 2008 |